...
search icon

Price related data not available

Analyst Forecast

Price related data not available

Returns

Time FrameKYTXSectorS&P500
1-Week Return5.29%0.45%-0.15%
1-Month Return38.93%0.25%0.99%
3-Month Return55.83%11.86%3.16%
6-Month Return204.56%15.5%11.21%
1-Year Return156.52%13.44%16.77%
3-Year Return-68.83%14.6%79.8%

Financials

Dec '21Dec '22Dec '23Dec '24
Total Revenue5.66M7.03M--[{"date":"2021-12-31","value":80.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue586.00K1.05M1.71M2.13M[{"date":"2021-12-31","value":27.47,"profit":true},{"date":"2022-12-31","value":49.27,"profit":true},{"date":"2023-12-31","value":80.03,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit5.66M7.03M(1.71M)(2.13M)[{"date":"2021-12-31","value":80.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-24.3,"profit":false},{"date":"2024-12-31","value":-30.36,"profit":false}]
Gross Margin100.00%100.00%--[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses32.00M36.41M60.70M140.47M[{"date":"2021-12-31","value":22.78,"profit":true},{"date":"2022-12-31","value":25.92,"profit":true},{"date":"2023-12-31","value":43.21,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(26.35M)(29.38M)(62.41M)(142.60M)[{"date":"2021-12-31","value":-2634600000,"profit":false},{"date":"2022-12-31","value":-2938400000,"profit":false},{"date":"2023-12-31","value":-6240600000,"profit":false},{"date":"2024-12-31","value":-14260400000,"profit":false}]
Total Non-Operating Income/Expense(6.00K)991.00K4.13M30.34M[{"date":"2021-12-31","value":-0.02,"profit":false},{"date":"2022-12-31","value":3.27,"profit":true},{"date":"2023-12-31","value":13.63,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(26.35M)(28.89M)(60.37M)(127.48M)[{"date":"2021-12-31","value":-2635000000,"profit":false},{"date":"2022-12-31","value":-2889300000,"profit":false},{"date":"2023-12-31","value":-6036600000,"profit":false},{"date":"2024-12-31","value":-12747700000,"profit":false}]
Income Taxes1.00K56.00K132.00K(127.48M)[{"date":"2021-12-31","value":0.76,"profit":true},{"date":"2022-12-31","value":42.42,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-96573.48,"profit":false}]
Income After Taxes(26.35M)(28.95M)(60.50M)-[{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(26.35M)(28.89M)(60.37M)(127.48M)[{"date":"2021-12-31","value":-2635000000,"profit":false},{"date":"2022-12-31","value":-2889300000,"profit":false},{"date":"2023-12-31","value":-6036600000,"profit":false},{"date":"2024-12-31","value":-12747700000,"profit":false}]
Income From Discontinued Operations----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(26.35M)(28.89M)(60.37M)(127.48M)[{"date":"2021-12-31","value":-2635000000,"profit":false},{"date":"2022-12-31","value":-2889300000,"profit":false},{"date":"2023-12-31","value":-6036600000,"profit":false},{"date":"2024-12-31","value":-12747700000,"profit":false}]
EPS (Diluted)--(26.86)(3.46)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-2686,"profit":false},{"date":"2024-12-31","value":-345.78,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

KYTX
Cash Ratio 5.05
Current Ratio 5.16

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KYTX
ROA (LTM) -40.75%
ROE (LTM) -70.82%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KYTX
Debt Ratio Lower is generally better. Negative is bad. 0.19
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.81

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KYTX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.69
Price/FCF NM
EV/R 3341.48
EV/Ebitda NM

FAQs

What is Kyverna Therapeutics, Inc. Common Stock share price today?

Kyverna Therapeutics, Inc. Common Stock (KYTX) share price today is $9.35

Can Indians buy Kyverna Therapeutics, Inc. Common Stock shares?

Yes, Indians can buy shares of Kyverna Therapeutics, Inc. Common Stock (KYTX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KYTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Kyverna Therapeutics, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Kyverna Therapeutics, Inc. Common Stock (KYTX) via the Vested app. You can start investing in Kyverna Therapeutics, Inc. Common Stock (KYTX) with a minimum investment of $1.

How to invest in Kyverna Therapeutics, Inc. Common Stock shares from India?

You can invest in shares of Kyverna Therapeutics, Inc. Common Stock (KYTX) via Vested in three simple steps:

  • Click on Sign Up or Invest in KYTX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Kyverna Therapeutics, Inc. Common Stock shares

What is Kyverna Therapeutics, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Kyverna Therapeutics, Inc. Common Stock (KYTX) is $13.67. The 52-week low price of Kyverna Therapeutics, Inc. Common Stock (KYTX) is $1.78.

What is Kyverna Therapeutics, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Kyverna Therapeutics, Inc. Common Stock (KYTX) is

What is Kyverna Therapeutics, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Kyverna Therapeutics, Inc. Common Stock (KYTX) is 3.69

What is Kyverna Therapeutics, Inc. Common Stock dividend yield?

The dividend yield of Kyverna Therapeutics, Inc. Common Stock (KYTX) is 0.00%

What is the Market Cap of Kyverna Therapeutics, Inc. Common Stock?

The market capitalization of Kyverna Therapeutics, Inc. Common Stock (KYTX) is $557.32M

What is Kyverna Therapeutics, Inc. Common Stock's stock symbol?

The stock symbol (or ticker) of Kyverna Therapeutics, Inc. Common Stock is KYTX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top